venBIO Partners
Venture Capital
Life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies for unmet medical needs.
San Francisco, United States · 29+ investments · 43 portfolio companies
Early Stage
Late Stage
Biotech
Healthcare
Life Sciences
- Headquarters
- San Francisco, United States
- Founded
- 2011
- Website
- venbio.com
- AUM
- $2.0B
- Portfolio Companies
- 43
- Total Investments
- 29
- Last Investment
- Jun 2026
- Geographic Focus
- United States
Investment Thesis
Life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies for unmet medical needs. Mission: optimize development for patient impact.
venBIO Partners is a Venture Capital firm based in San Francisco, United States. It has made 29 investments in Biotech and Healthcare, including Insamo, Candid Therapeutics and Alumis.
Portfolio43
SP
Seragon PharmaceuticalsCP
Checkmate Pharmaceuticals
YT
Yarrow Therapeutics
IT
Isotovia Therapeutics
TP
Turning Point TherapeuticsMT
Marrow Therapeutics
IB
Immpact BioAP
Aragon Pharmaceuticals
RB
Rayze BioMM
Mass MedicinesLB
Labrys Biologics
ET
Eyconis TherapeuticsNT
Niuvera TherapeuticsAO
ALX OncologyInvestment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.